Characterization of squalene epoxidase activity from the dermatophyte Trichophyton rubrum and its inhibition by terbinafine and other antimycotic agents

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 2, 1996, Pages 443-447

  Favre, Bertrand ^a   Ryder, Neil S ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

3 CHLORO N (6,6 DIMETHYL 2 HEPTEN 4 YNYL) N METHYLBENZO[B]THIOPHENE 7 METHANAMINE; AMOROLFINE; ANTIFUNGAL AGENT; MICROSOME ENZYME; NAFTIFINE; SQUALENE MONOOXYGENASE; TERBINAFINE; THIOCARBAMIC ACID DERIVATIVE; TOLCICLATE; TOLNAFTATE;

ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG MECHANISM; DRUG POTENCY; DRUG TARGETING; ENZYME ISOLATION; NONHUMAN; PRIORITY JOURNAL; SKIN INFECTION; STEROL SYNTHESIS; STRUCTURE ACTIVITY RELATION; TRICHOPHYTON RUBRUM; TRICHOPHYTOSIS;

EID: 0030064141     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.2.443     Document Type: Article

References (40)

1. Abe, I., J. C. Tomesch, S. Wattanasin, and G. D. Prestwich. 1994. Inhibitors of squalene biosynthesis and metabolism. Nat. Prod. Rep. 11:279-302.
2. Bai, M., and G. D. Prestwich. 1992 Inhibition and activation of porcine squalene epoxidase. Arch. Biochem. Biophys. 293:305-313.
3. Barrett-Bee, K., A. C. Lane, and R. W. Turner. 1986 The mode of antifungal action of tolnaftate. J Med. Vet. Mycol. 24:155-160.
4. deCarneri, I., G. Monti, A. Bianchi, S. Castellino, G. Meinardi, and V. Mandelli. 1976. Tolciclate against dermatophytes. Drug Res. 26:769-772.
5. Dennerancona, P., M. Bai, H. K. Lee, I. Abe, and G. D. Prestwich. 1995. Purification of pig and rat liver squalene epoxidase by affinity chromatography Bioorg Med. Chem. Lett. 5:481-486
6. Friedlander, E. J., I. J. Caras, L. F. H. Lin, and K. Bloch. 1980. Supernatant protein factor facilitates intermembrane transfer of squalene. J. Biol. Chem. 255:8042-8045.
7. Georgopapadakou, N. H., and T. J. Walsh. 1994. Human mycoses - drugs and targets for emerging pathogens. Science 264:371-373.
8. Iyanagi, T., R. Makino, and F. K. Anan. 1981. Studies on the microsomal mixed-function oxidase system: mechanism of action of hepatic NADPH-cytochrome P-450 reductase. Biochemistry 20:1722-1730.
9. Jahnke, L., and H. P. Klein. 1983. Oxygen requirements for formation and activity of the squalene epoxidase in Saccharomyces cerevisiae. J Bacteriol 155:488-492.
10. Jandrositz, A., F. Turnowsky, and G. Hoegenauer. 1991. The gene encoding squalene epoxidase from Saccharomyces cerevisiae cloning and characterization Gene 107:155-160.
11. M'Baya, B., and F. Karst. 1987. In vitro assay of squalene epoxidase of Saccharomyces cerevisiae. Biochem Biophys. Res Commun. 147:556-564.
12. Moreau, J. P., P. J. Ramm, and E. Caspi. 1975. Biosynthesis of sterols by a yeast homogenate Incorporation of mevalonic acid into cholesta-5,7,24-trien-3beta-ol and 5alpha-cholesta-7,24-dien-3beta-ol. Eur. J. Biochem. 56: 393-402.
13. Morita, T., and Y. Nozawa. 1985. Effects of antifungal agents on ergosterol biosynthesis in Candida albicans and Trichophyton mentagrophytes: differential inhibitory sites of naphthiomates and miconazole J. Invest Dermatol. 85:434-437.
14. Nussbaumer, P., I. Leitner, K. Mraz, and A. Stuetz. 1995. Synthesis and structure-activity relationships of side-chain substituted analogs of the allylamine antimycotic terbinafine lacking the central amino function. J Med. Chem. 38:1831-1836.
15. Nussbaumer, P., G. Petranyi, and A. Stuetz. 1991. Synthesis and structure activity relationships of benzo[b]thienylallylamine antimycotics. J. Med. Chem. 34:65-73.
16. Nussbaumer, P., N. S. Ryder, and A. Stuetz. 1991. Allylamine antimycotics: recent trends in structure-activity relationships and syntheses. Pestic. Sci. 31: 437-455
17. Ono, T., and K. Bloch. 1975 Solubilization and partial characterization of rat liver squalene epoxidase. J Biol Chem. 250:1571-1579.
18. Ono, T., K. Nakazono, and H. Kosaka. 1982. Purification and partial characterization of squalene epoxidase from rat liver microsomes. Biochim Biophys. Acta 709:84-90.
19. Ono, T., S. Ozasa, F. Hasegawa, and Y. Imai. 1977 Involvement of NADPH-cytochrome c reductase in the rat liver squalene epoxidase system. Biochim. Biophys. Acta 486:401-407
20. Petranyi, G., J. G. Meingassner, and H. Mieth. 1987. Antifungal activity of the allylamine derivative terbinafine in vitro. Antimicrob. Agents Chemother. 31:1365-1368.
21. Polak, A. 1988. Mode of action of dimethylmorpholine derivatives. Ann. N Y. Acad Sci. 544:221-228.
22. Ryder, N. S. 1985. Specific inhibition of fungal sterol biosynthesis by SF 86-327, a new allylamine antimycotic agent. Antimicrob Agents Chemother. 27:252-256.
23. Ryder, N. S. 1987. Squalene epoxidase as the target of antifungal allylamines. Pestic. Sci 21:281-288.
24. Ryder, N. S. 1988. Mechanism of action and biochemical selectivity of allylamine antimycotic agents. Ann. N. Y. Acad. Sci. 544:208-220.
25. Ryder, N. S. 1990. Squalene epoxidase: enzymology and inhibition, p 189-203 In P. J. Kuhn, A. P. J. Trinci, M. J. Jung, M. W. Goosey, and L G. Copping (ed.), Biochemistry of cell walls and membranes in fungi. Springer-Verlag, Berlin.
26. Ryder, N. S. 1992. Terbinafine: mode of action and properties of the squalene epoxidase inhibition. Br. J. Dermatol. 126(Suppl. 39):2-7.
27. Ryder, N. S., and M.-C. Dupont. 1984. Properties of a particulate squalene epoxidase from Candida albicans. Biochim. Biophys Acta 794:466-471
28. Ryder, N. S., and M.-C. Dupont. 1985. Inhibition of squalene epoxidase by allylamine antimycotic compounds A comparative study of the fungal and mammalian enzymes Biochem. J. 230:765-770
29. Ryder, N. S., I. Frank, and M.-C. Dupont. 1986. Ergosterol biosynthesis inhibition by the thiocarbamate antifungal agents tolnaftate and tolciclate. Antimicrob. Agents Chemother. 29:858-860.
30. Ryder, N. S., and H. Mieth. 1991. Allylamine antifungal drugs. Curr. Top. Med. Mycol. 4:158-188.
31. Ryder, N. S., G. Seidl, and P. F. Troke. 1984. Effect of the antimycotic drug naftifine on growth of and sterol biosynthesis in Candida albicans. Antimicrob Agents Chemother. 25:483-487
32. Ryder, N. S., A. Stuetz, and P. Nussbaumer. 1992. Squalene epoxidase inhibitors: structural determinants for activity and selectivity of allylamines and related compounds, p. 192-204. In W. D. Nes, E. J Parish, and J. M. Trzaskos (ed.), Regulation of isopentenoid metabolism. American Chemical Society, Washington, D.C.
33. Sakakibara, J., R. Watanabe, Y. Kanai, and T. Ono. 1995. Molecular cloning and expression of rat squalene epoxidase J Biol. Chem. 270:17-20
34. Satoh, T., M. Horie, H. Watanabe, Y. Tsuchiya, and T. Kamei. 1993. Enzymatic properties of squalene epoxidase from Saccharomyces cerevisiae. Biol. Pharm. Bull. 16:349-352.
35. Stuetz, A., and P. Nussbaumer. 1989. SDZ 87-469. Drugs Fut. 14:639-642.
36. Stuetz, A., and G. Petranyi. 1984. Synthesis and antifungal activity of (E)-N-(6,6-dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalenemethanamine (SF 86-327) and related allylamine derivatives with enhanced oral activity. J. Med Chem 27:1539-1543.
37. Troke, P. F. 1993. In vitro and experimental in vivo activities of fluconazole against some fungi causing cutaneous mycoses, p. 199-214. In J. W. Rippon and R. A. Fromtling (ed.), Cutaneous antifungal agents. Selected compounds in clinical practice and development. Marcel Dekker, Inc., New York.
38. Vanden Bossche, H., J. Heeres, L. J. J. Backx, P. Marichal, and G. Willemsens. 1993. Discovery, chemistry, mode of action, and selectivity of itraconazole, p 263-283 In J. W Rippon and R A. Fromtling (ed), Cutaneous antifungal agents. Selected compounds in clinical practice and development. Marcel Dekker, Inc., New York
39. Villars, V. V., and T. C. Jones. 1993. Clinical use of oral and topical terbinafine in the treatment of fungal diseases, p. 151-168. In J. W. Rippon and R. A. Fromtling (ed.), Cutaneous antifungal agents. Selected compounds in clinical practice and development. Marcel Dekker, Inc., New York
40. Wildfeuer, A., and T. Rozman. 1984. Antimycotic efficacy of tolciclate. Mykosen 27:142-152.